menu search
Trades24h logo
 Register
close Tap here to search
  1. Home

  2. News

  3. Stock Details

Subscribe To  

  Price Alert   Latest News   Economic Calendar News

CERE / Cerevel Therapeutics Holdings, Inc. (CERE) Q3 2022 Earnings Call Transcript

Cerevel Therapeutics Holdings, Inc. (CERE) Q3 2022 Earnings Call Transcript
Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE ) Q3 2022 Earnings Conference Call November 8, 2022 8:00 AM ET Company Participants Matt Calistri - Vice President of Corporate Strategy and Investor Relations Anthony Coles - Chairperson and Chief Executive Officer Raymond Sanchez - Chief Medical Officer John Renger - Chief Scientific Officer Mark Bodenrader - Interim Chief Financial Officer Abraham Ceesay - President Conference Call Participants Umer Raffat - Evercore Michael Yee - Jefferies Paul Matteis - Stifel Tazeen Ahmad - Bank of America Max Skor - Morgan Stanley Mohit Bansal - Wells Fargo Rob Palermo - Goldman Sachs Charles Duncan - Cantor Fitzgerad Douglas Tsao - H.C. Wainwright Operator Good morning, and welcome to the Cerevel Therapeutics Third Quarter 2022 Financial Results Conference Call. Read More
Hmarkets Logo
Demo chevron_right Live Account chevron_right See Partner Details

Content Topics

Cerevel

Therapeutics

Holdings

Inc

CERE

2022

Earnings

Holdings

cere

Transcript

Stock

Posted: Nov 13 2022, 00:43
Author Name: Seeking Alpha
Views: 102880

CERE News  

Cerevel Therapeutics to Report Third Quarter 2023 Financial Results and Business Updates on Wednesday, November 1, 2023

By GlobeNewsWire
October 13, 2023

Cerevel Therapeutics to Report Third Quarter 2023 Financial Results and Business Updates on Wednesday, November 1, 2023

CAMBRIDGE, Mass., Oct. 13, 2023 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain more_horizontal

Cerevel Therapeutics to Present at Morgan Stanley 21st Annual Global Healthcare Conference

By GlobeNewsWire
August 29, 2023

Cerevel Therapeutics to Present at Morgan Stanley 21st Annual Global Healthcare Conference

CAMBRIDGE, Mass., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Cerevel Therapeutics, (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain more_horizontal

Why Shares of Cerevel Therapeutics Are Dropping Wednesday

By The Motley Fool
August 2, 2023

Why Shares of Cerevel Therapeutics Are Dropping Wednesday

Cerevel said it is experiencing delays in some of its clinical trials. The company appointed a new CEO in June. more_horizontal

Cerevel Therapeutics to Report Second Quarter 2023 Financial Results and Business Updates on Wednesday, August 2, 2023

By GlobeNewsWire
July 5, 2023

Cerevel Therapeutics to Report Second Quarter 2023 Financial Results and Business Updates on Wednesday, August 2, 2023

CAMBRIDGE, Mass., July 05, 2023 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain more_horizontal

Cerevel: High Priced Stock Doing Interesting Science

By Seeking Alpha
June 4, 2023

Cerevel: High Priced Stock Doing Interesting Science

Cerevel has some interesting data in various CNS indications. However, the company has a very high valuation. It seems a lot of the company's potentia more_horizontal

Cerevel Therapeutics Holdings, Inc. (CERE) Q1 2023 Earnings Call Transcript

By Seeking Alpha
May 7, 2023

Cerevel Therapeutics Holdings, Inc. (CERE) Q1 2023 Earnings Call Transcript

Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE ) Q1 2023 Earnings Conference Call May 3, 2023 8:00 AM ET Company Participants Matthew Calistri - Vic more_horizontal

Cerevel Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Business Updates on Wednesday, February 22, 2023

By GlobeNewsWire
February 1, 2023

Cerevel Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Business Updates on Wednesday, February 22, 2023

CAMBRIDGE, Mass., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain more_horizontal

Cerevel Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference and Provide Pipeline Update

By GlobeNewsWire
January 9, 2023

Cerevel Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference and Provide Pipeline Update

Initiated Phase 1 healthy volunteer trial to support development of emraclidine in Alzheimer's disease psychosis in Q4 2022; second potential indicati more_horizontal

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

©2014-2024 All Rights Reserved. I.C

Hand-crafted & made with Love

logo close

Search within

Pages Search Results: